1. Home
  2. RLYB vs MNDO Comparison

RLYB vs MNDO Comparison

Compare RLYB & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$0.69

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

HOLD

Current Price

$1.17

Market Cap

23.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLYB
MNDO
Founded
2018
1995
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
24.1M
23.6M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
RLYB
MNDO
Price
$0.69
$1.17
Analyst Decision
Hold
Analyst Count
2
0
Target Price
N/A
N/A
AVG Volume (30 Days)
185.6K
30.6K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
18.80%
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$674,000.00
$19,770,000.00
Revenue This Year
$17.61
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$8.36
Revenue Growth
12.71
N/A
52 Week Low
$0.22
$0.98
52 Week High
$1.08
$2.13

Technical Indicators

Market Signals
Indicator
RLYB
MNDO
Relative Strength Index (RSI) 49.41 43.88
Support Level $0.71 $1.18
Resistance Level $0.80 $1.22
Average True Range (ATR) 0.06 0.03
MACD -0.00 -0.01
Stochastic Oscillator 44.06 2.89

Price Performance

Historical Comparison
RLYB
MNDO

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

Share on Social Networks: